Fig. 4
From: Uptake of new antidiabetic medicines in 11 European countries
Correlation between the ratio (2011 compared to 2007) of intensity of prescribing policy for all antidiabetic medicines and volume market share of incretin-based medicines (DDP-4 inhibitors and GLP-1 receptor agonists) in 2011